Palisade Bio Participates in Virtual Investor "What this Means" Segment

Carlsbad, CA, July 31, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) (the "Company"), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced the release of a Virtual Investor "What This Means" segment. About Palisade Bio JTC Team, LLC Jenene Thomas 833-475-8247 PALI@jtcir.com Mitch Jones, MD, PhD, CMO of Palisade Bio highlights recent findings from a microbiome study confirming l ...